Industries · Pharmaceuticals

SAP batch data for pharma that holds up under a GxP audit

Batch records, material master data and validation environments have to stay traceable under GxP and FDA 21 CFR Part 11.

Focus
Batch & material master data
Compliance
GxP, FDA 21 CFR Part 11

The problem

A batch management change nobody wants to own

Batch numbering, material master structures and manufacturing execution data have to stay traceable, or a GxP audit becomes a problem. Most pharma companies inherit batch setups nobody fully documented.

Validation and test environments carry the same weight. If test data doesn't reflect real batch and material structures, the validation isn't testing what production will actually run.

Where we help

SAP batch management for pharma

GxP-ready test data

Provision validation systems with production-like batch and material data, masked where needed.

Clean material master data

Deduplicate and standardize material and batch master data before it feeds production.

Benefits

What you get

  • Traceable batch changes

    Every batch management change planned, simulated and logged before it's executed.

  • GxP-ready test data

    Validation environments that reflect real batch and material structures, not stale copies.

  • Clean material & batch master data

    Consistent structures across manufacturing execution and SAP.

  • Audit-ready data through migration

    Batch history and quality records intact when they land in SAP S/4HANA.

Other industries

Where else we work

Our Partners

  • Korcomptenz
  • Kellton
  • Datafy
  • Veralogics
  • Techwave
  • Consulting Solutions
  • LG CNS
  • MediMo Global

Next step

Talk to the people who build the tools

Bring your batch management or pharma data problem to the people who build the tools.

Scroll to Top